Clinical Trial Comparing Tissue Adhesive Vs. Absorbable Suture Vs. Non-Absorbable Suture
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00292513 |
Recruitment Status : Unknown
Verified May 2005 by Rady Children's Hospital, San Diego.
Recruitment status was: Recruiting
First Posted : February 16, 2006
Last Update Posted : February 16, 2006
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cyst of Face, Neck or Shoulder Pilomatrixoma of Face, Neck or Shoulder | Device: standard suture (5-0 prolene), topical skin adhesive (dermabond), absorbable suture (5-0 Chromic gut) | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | A Randomized Clinical Trial Comparing Tissue Adhesive (2-Octylcyanoacrylate) Vs. Absorbable Suture Vs. Non-Absorbable Suture for the Closure of Low Tension Facial and Neck Wounds in Children and Adolescents |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 0 Years to 18 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Inclusion Criteria:
- Age less than or equal to 18
- Pre-operative diagnosis of cyst or pilomatrixoma of neck, face or shoulder
- outpatient scheduled for outpatient or day surgery at Children's Hospital San Diego
Exclusion Criteria:
- known hypersensitivity to cyanoacrylate or formaldehyde
- lesions with any evidence of active infection or gangrene
- lesions on or across mucocutaneous surfaces
- lesions in which skin may be regularly exposed to body fluids
- lesions located in areas of dense natural hair (ie scalp)
- patients with peripheral vascular disease, insulin dependent diabetes mellitis or blood clotting disorders
- patients with known immunodeficiencies
- inability to return for follow-up

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00292513
Contact: Bari B Cunningham, MD | 858-576-1700 ext 4270 | bcunningham@chsd.org |
United States, California | |
Children's Hospital San Diego | Recruiting |
San Diego, California, United States, 92123 | |
Principal Investigator: Bari B Cunningham, MD | |
Sub-Investigator: Sheila F Friedlander, MD | |
Sub-Investigator: Lawrence F Eichenfield, MD | |
Sub-Investigator: Brandie Roberts, MD | |
Sub-Investigator: Magdalene Dohil, MD |
Principal Investigator: | Bari B Cunningham, MD | Rady Children's Hospital, San Diego |
ClinicalTrials.gov Identifier: | NCT00292513 |
Other Study ID Numbers: |
Dermabond Study |
First Posted: | February 16, 2006 Key Record Dates |
Last Update Posted: | February 16, 2006 |
Last Verified: | May 2005 |
Pilomatrixoma Neoplasms, Basal Cell Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms |